Top 5 Stocks to Buy Now
→ Read now. Do not delete. You’ve been warned. (From Porter & Company) (Ad)tc pixel Free OPTI Stock Alerts

OptiBiotix Health (OPTI) Competitors

OptiBiotix Health logo
GBX 6.18 +0.24 (+3.95%)
As of 11:46 AM Eastern
Compare

OPTI vs. CRDL, OKYO, IGAS, ALT, and PHE

Should you buy OptiBiotix Health stock or one of its competitors? MarketBeat compares OptiBiotix Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with OptiBiotix Health include Cordel Group (CRDL), OKYO Pharma (OKYO), IGas Energy (IGAS), Altitude Group (ALT), and PowerHouse Energy Group (PHE). These companies are all part of the "pharmaceutical products" industry.

How does OptiBiotix Health compare to Cordel Group?

OptiBiotix Health (LON:OPTI) and Cordel Group (LON:CRDL) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership.

Cordel Group has a net margin of -27.15% compared to OptiBiotix Health's net margin of -333.62%. Cordel Group's return on equity of -44.78% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
OptiBiotix Health-333.62% -52.92% -13.93%
Cordel Group -27.15%-44.78%-7.25%

Cordel Group has higher revenue and earnings than OptiBiotix Health. Cordel Group is trading at a lower price-to-earnings ratio than OptiBiotix Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OptiBiotix Health£1.17M5.48-£3.09M-£3.84N/A
Cordel Group£4.24M6.10-£1.41M-£0.53N/A

OptiBiotix Health has a beta of 1.85, indicating that its stock price is 85% more volatile than the broader market. Comparatively, Cordel Group has a beta of 0.623, indicating that its stock price is 38% less volatile than the broader market.

In the previous week, OptiBiotix Health's average media sentiment score of 0.00 equaled Cordel Group'saverage media sentiment score.

Company Overall Sentiment
OptiBiotix Health Neutral
Cordel Group Neutral

0.4% of OptiBiotix Health shares are held by institutional investors. Comparatively, 4.3% of Cordel Group shares are held by institutional investors. 26.8% of OptiBiotix Health shares are held by company insiders. Comparatively, 33.2% of Cordel Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Cordel Group beats OptiBiotix Health on 9 of the 11 factors compared between the two stocks.

How does OptiBiotix Health compare to OKYO Pharma?

OKYO Pharma (LON:OKYO) and OptiBiotix Health (LON:OPTI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.

OKYO Pharma has a net margin of 0.00% compared to OptiBiotix Health's net margin of -333.62%. OptiBiotix Health's return on equity of -52.92% beat OKYO Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
OKYO PharmaN/A -397.13% -154.72%
OptiBiotix Health -333.62%-52.92%-13.93%

OKYO Pharma has a beta of -0.06, indicating that its share price is 106% less volatile than the broader market. Comparatively, OptiBiotix Health has a beta of 1.85, indicating that its share price is 85% more volatile than the broader market.

0.4% of OptiBiotix Health shares are held by institutional investors. 31.9% of OKYO Pharma shares are held by company insiders. Comparatively, 26.8% of OptiBiotix Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, OKYO Pharma's average media sentiment score of 0.00 equaled OptiBiotix Health'saverage media sentiment score.

Company Overall Sentiment
OKYO Pharma Neutral
OptiBiotix Health Neutral

OptiBiotix Health has higher revenue and earnings than OKYO Pharma. OptiBiotix Health is trading at a lower price-to-earnings ratio than OKYO Pharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OKYO PharmaN/AN/A-£6.70M-£0.01N/A
OptiBiotix Health£1.17M5.48-£3.09M-£3.84N/A

Summary

OptiBiotix Health beats OKYO Pharma on 7 of the 10 factors compared between the two stocks.

How does OptiBiotix Health compare to IGas Energy?

IGas Energy (LON:IGAS) and OptiBiotix Health (LON:OPTI) are both small-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

OptiBiotix Health has lower revenue, but higher earnings than IGas Energy. OptiBiotix Health is trading at a lower price-to-earnings ratio than IGas Energy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IGas Energy£59.17M0.00-£11.78M-£0.10N/A
OptiBiotix Health£1.17M5.48-£3.09M-£3.84N/A

IGas Energy has a net margin of -19.91% compared to OptiBiotix Health's net margin of -333.62%. IGas Energy's return on equity of -18.56% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
IGas Energy-19.91% -18.56% -5.66%
OptiBiotix Health -333.62%-52.92%-13.93%

55.7% of IGas Energy shares are held by institutional investors. Comparatively, 0.4% of OptiBiotix Health shares are held by institutional investors. 3.3% of IGas Energy shares are held by insiders. Comparatively, 26.8% of OptiBiotix Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, IGas Energy's average media sentiment score of 0.00 equaled OptiBiotix Health'saverage media sentiment score.

Company Overall Sentiment
IGas Energy Neutral
OptiBiotix Health Neutral

IGas Energy has a beta of -0.04, indicating that its share price is 104% less volatile than the broader market. Comparatively, OptiBiotix Health has a beta of 1.85, indicating that its share price is 85% more volatile than the broader market.

Summary

IGas Energy beats OptiBiotix Health on 6 of the 10 factors compared between the two stocks.

How does OptiBiotix Health compare to Altitude Group?

OptiBiotix Health (LON:OPTI) and Altitude Group (LON:ALT) are both small-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

0.4% of OptiBiotix Health shares are held by institutional investors. Comparatively, 6.4% of Altitude Group shares are held by institutional investors. 26.8% of OptiBiotix Health shares are held by company insiders. Comparatively, 38.8% of Altitude Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Altitude Group had 1 more articles in the media than OptiBiotix Health. MarketBeat recorded 1 mentions for Altitude Group and 0 mentions for OptiBiotix Health. OptiBiotix Health's average media sentiment score of 0.00 equaled Altitude Group'saverage media sentiment score.

Company Overall Sentiment
OptiBiotix Health Neutral
Altitude Group Neutral

OptiBiotix Health has a beta of 1.85, meaning that its share price is 85% more volatile than the broader market. Comparatively, Altitude Group has a beta of 0.608, meaning that its share price is 39% less volatile than the broader market.

Altitude Group has higher revenue and earnings than OptiBiotix Health. OptiBiotix Health is trading at a lower price-to-earnings ratio than Altitude Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OptiBiotix Health£1.17M5.48-£3.09M-£3.84N/A
Altitude Group£40.47M0.44£682.34K£0.7632.36

Altitude Group has a net margin of 0.00% compared to OptiBiotix Health's net margin of -333.62%. Altitude Group's return on equity of 0.00% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
OptiBiotix Health-333.62% -52.92% -13.93%
Altitude Group 0.00%0.00%1.65%

Summary

Altitude Group beats OptiBiotix Health on 10 of the 12 factors compared between the two stocks.

How does OptiBiotix Health compare to PowerHouse Energy Group?

OptiBiotix Health (LON:OPTI) and PowerHouse Energy Group (LON:PHE) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

OptiBiotix Health has a beta of 1.85, suggesting that its stock price is 85% more volatile than the broader market. Comparatively, PowerHouse Energy Group has a beta of 1.75, suggesting that its stock price is 75% more volatile than the broader market.

OptiBiotix Health has a net margin of -333.62% compared to PowerHouse Energy Group's net margin of -913.32%. OptiBiotix Health's return on equity of -52.92% beat PowerHouse Energy Group's return on equity.

Company Net Margins Return on Equity Return on Assets
OptiBiotix Health-333.62% -52.92% -13.93%
PowerHouse Energy Group -913.32%-115.89%-17.45%

0.4% of OptiBiotix Health shares are owned by institutional investors. Comparatively, 0.1% of PowerHouse Energy Group shares are owned by institutional investors. 26.8% of OptiBiotix Health shares are owned by company insiders. Comparatively, 4.5% of PowerHouse Energy Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

PowerHouse Energy Group has lower revenue, but higher earnings than OptiBiotix Health. PowerHouse Energy Group is trading at a lower price-to-earnings ratio than OptiBiotix Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OptiBiotix Health£1.17M5.48-£3.09M-£3.84N/A
PowerHouse Energy Group£588.58K20.01-£2.22M-£0.12N/A

In the previous week, OptiBiotix Health's average media sentiment score of 0.00 equaled PowerHouse Energy Group'saverage media sentiment score.

Company Overall Sentiment
OptiBiotix Health Neutral
PowerHouse Energy Group Neutral

Summary

OptiBiotix Health beats PowerHouse Energy Group on 8 of the 11 factors compared between the two stocks.

Get OptiBiotix Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPTI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OPTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPTI vs. The Competition

Export
MetricOptiBiotix HealthBiotechnology IndustryMedical SectorLON Exchange
Market Cap£6.39M£467.51M£6.48B£2.78B
Dividend YieldN/A3.86%2.68%6.16%
P/E Ratio-1.613.1824.66365.72
Price / Sales5.486,492.90529.8986,253.73
Price / Cash8.6813.1327.9227.85
Price / Book0.7991.5010.847.93
Net Income-£3.09M-£96.07M£3.56B£5.89B
7 Day Performance-0.24%1.66%1.71%-0.87%
1 Month Performance12.45%0.74%0.48%-0.76%
1 Year Performance-45.65%64.24%32.98%70.67%

OptiBiotix Health Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPTI
OptiBiotix Health
N/AGBX 6.19
+3.9%		N/A-50.4%£6.39M£1.17MN/A1
CRDL
Cordel Group
N/AGBX 11.80
-0.8%		N/A+59.2%£25.60M£4.24MN/A35
OKYO
OKYO Pharma
N/AN/AN/AN/A£23.24MN/AN/A7
IGAS
IGas Energy
N/AN/AN/AN/A£18.97M£59.17MN/A100
ALT
Altitude Group
N/AGBX 24.94
+3.9%		N/A-3.5%£18.25M£40.47M32.8250

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:OPTI) was last updated on 6/23/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel